Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 32 Breast Neoplasms 18 Neoplasms 9 Triple Negative Breast Neoplasms 8 Neoplasm Metastasis 7 Sarcoma 6 Prostatic Neoplasms 6 Fanconi Anemia, Complementation Group D1 6 Pancreatic Neoplasms 5 Endometrial Neoplasms 5 Stomach Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Small Cell Lung Carcinoma 4 Recurrence 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Fallopian Tube Neoplasms 4 Colorectal Neoplasms 4 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Mesothelioma 2 Head and Neck Neoplasms 2 Glioma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Advanced Solid Tumours 2 Advanced Solid Tumors 2 Wilms Tumor 1

Interventions

Fulvestrant 5 Anastrozole 4 Letrozole 3 Docetaxel 2 Dasatinib 2 vandetanib 1 sonidegib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 olaparib 1 irinotecan sucrosofate 1 exemestane 1 cediranib 1 XMT-1522 1 Vorinostat 1 Tablets 1 Ritonavir 1 Population Groups 1 Paclitaxel 1 Moxifloxacin 1 Itraconazole 1 Histone Deacetylase Inhibitors 1 Gemcitabine 1 FCN-437c 1 Everolimus 1 Electroporation 1 Cryosurgery 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Breast Cancer × olaparib × Clear all

NCT03205761 2024-10-18

COMETABreast

Spanish Breast Cancer Research Group

Phase 2 Completed

11 enrolled 20 charts

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡